SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 214 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $366,000 | -62.3% | 20,400 | -50.2% | 0.19% | +70.2% |
| Q4 2019 | $972,000 | -2.7% | 41,000 | +1.5% | 0.11% | +40.7% |
| Q3 2016 | $999,000 | -53.3% | 40,400 | -74.6% | 0.08% | -70.2% |
| Q4 2015 | $2,138,000 | -4.1% | 159,100 | 0.0% | 0.27% | -6.2% |
| Q3 2015 | $2,230,000 | -32.6% | 159,100 | -18.4% | 0.29% | -37.2% |
| Q2 2015 | $3,307,000 | +64.7% | 194,900 | +17.2% | 0.46% | +65.0% |
| Q1 2015 | $2,008,000 | +145.5% | 166,300 | +68.8% | 0.28% | +104.4% |
| Q4 2014 | $818,000 | – | 98,500 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |